229 related articles for article (PubMed ID: 33375357)
1. Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY).
Tubin S; Gupta S; Grusch M; Popper HH; Brcic L; Ashdown ML; Khleif SN; Peter-Vörösmarty B; Hyden M; Negrini S; Fossati P; Hug E
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375357
[TBL] [Abstract][Full Text] [Related]
2. Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment.
Tubin S; Ashdown M; Jeremic B
Radiat Oncol; 2019 Dec; 14(1):220. PubMed ID: 31801549
[TBL] [Abstract][Full Text] [Related]
3. Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment.
Tubin S; Khan MK; Salerno G; Mourad WF; Yan W; Jeremic B
Radiat Oncol; 2019 Nov; 14(1):212. PubMed ID: 31771654
[TBL] [Abstract][Full Text] [Related]
4. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Tubin S; Popper HH; Brcic L
Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
[TBL] [Abstract][Full Text] [Related]
5. Partial-Volume Irradiation of Murine Tumors.
Modic Z; Markelc B; Jesenko T
Methods Mol Biol; 2024; 2773():97-104. PubMed ID: 38236540
[TBL] [Abstract][Full Text] [Related]
6. Spatially fractionated radiotherapy (SFRT) targeting the hypoxic tumor segment for the intentional induction of non-targeted effects: An
Massaccesi M; Boldrini L; Piras A; Stimato G; Quaranta F; Azario L; Mattiucci GC; Valentini V
Tech Innov Patient Support Radiat Oncol; 2020 Jun; 14():11-14. PubMed ID: 32154394
[TBL] [Abstract][Full Text] [Related]
7. Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety.
Tubin S; Fossati P; Carlino A; Martino G; Gora J; Stock M; Hug E
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565361
[TBL] [Abstract][Full Text] [Related]
8. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.
Tubin S; Yan W; Mourad WF; Fossati P; Khan MK
Future Oncol; 2020 Jun; 16(16):1137-1151. PubMed ID: 32338046
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.
Popp I; Grosu AL; Niedermann G; Duda DG
Radiother Oncol; 2016 Aug; 120(2):185-94. PubMed ID: 27495145
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy Immunological Planning-A Review With a Proposed Theoretical Model.
Swamy K
Front Oncol; 2022; 12():729250. PubMed ID: 35155221
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery.
Kim MS; Kim W; Park IH; Kim HJ; Lee E; Jung JH; Cho LC; Song CW
Radiat Oncol J; 2015 Dec; 33(4):265-75. PubMed ID: 26756026
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis.
Zhang X; Zhang Y; Liu Y; Yang Y; Dong P; He L; Zhou F
Transl Androl Urol; 2021 Nov; 10(11):4304-4312. PubMed ID: 34984195
[TBL] [Abstract][Full Text] [Related]
13. Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity.
Lai JZ; Zhu YY; Liu Y; Zhou LL; Hu L; Chen L; Zhang QY
Front Oncol; 2021; 11():690188. PubMed ID: 34249740
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for lung metastases in a patient with giant cell tumor of bone: a case report and literature review.
Feng L; Ye T; Zhang J; Yuan S; Chen Y; Chen J
Ann Transl Med; 2022 Feb; 10(3):156. PubMed ID: 35284555
[TBL] [Abstract][Full Text] [Related]
15. The radiobiological targets of SBRT: tumor cells or endothelial cells?
Karam SD; Bhatia S
Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
[TBL] [Abstract][Full Text] [Related]
16. [Non-targeted effects (bystander, abscopal) of external beam radiation therapy: an overview for the clinician].
Sun R; Sbai A; Ganem G; Boudabous M; Collin F; Marcy PY; Doglio A; Thariat J
Cancer Radiother; 2014 Dec; 18(8):770-8. PubMed ID: 25451674
[TBL] [Abstract][Full Text] [Related]
17. Novel unconventional radiotherapy techniques: Current status and future perspectives - Report from the 2nd international radiation oncology online seminar.
Tubin S; Vozenin MC; Prezado Y; Durante M; Prise KM; Lara PC; Greco C; Massaccesi M; Guha C; Wu X; Mohiuddin MM; Vestergaard A; Bassler N; Gupta S; Stock M; Timmerman R
Clin Transl Radiat Oncol; 2023 May; 40():100605. PubMed ID: 36910025
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
19. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models.
Markovsky E; Budhu S; Samstein RM; Li H; Russell J; Zhang Z; Drill E; Bodden C; Chen Q; Powell SN; Merghoub T; Wolchok JD; Humm J; Deasy JO; Haimovitz-Friedman A
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):697-708. PubMed ID: 30342090
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.
Fan TM; Selting KA
Front Oncol; 2018; 8():680. PubMed ID: 30697532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
